Keel Point, LLC Astrazeneca PLC Transaction History

Keel Point, LLC

$977 Million
Q1 2024

A detailed history of Keel Point, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Keel Point, LLC holds 5,827 shares of AZN stock, worth $447,513. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,827

Previous 5,042 15.57%

Holding current value

$447,513

Previous $339,000 16.22%

% of portfolio

0.04%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$61.03 - $69.57 $47,908 - $54,612	785 Added 15.57%	5,827 $394,000
Q4 2023 Jan 30, 2024	BUY	$61.89 - $69.28 $8,478 - $9,491	137 Added 2.79%	5,042 $339,000
Q3 2023 Oct 26, 2023	SELL	$64.85 - $71.7 $61,996 - $68,545	-956 Reduced 16.31%	4,905 $332,000
Q2 2023 Jul 12, 2023	SELL	$69.91 - $75.81 $29,991 - $32,522	-429 Reduced 6.82%	5,861 $419,000
Q1 2023 Apr 03, 2023	SELL	$63.15 - $71.6 $25,702 - $29,141	-407 Reduced 6.08%	6,290 $436,000

Q4 2022 Jan 17, 2023	BUY	$54.21 - $70.44 $33,447 - $43,461	617 Added 10.15%	6,697 $0
Q3 2022 Oct 05, 2022	BUY	$53.02 - $135.75 $3,128 - $8,009	59 Added 0.98%	6,080 $333,000
Q2 2022 Aug 11, 2022	BUY	$59.26 - $71.14 $40,711 - $48,873	687 Added 12.88%	6,021 $399,000
Q1 2022 Apr 27, 2022	SELL	$55.72 - $67.12 $15,657 - $18,860	-281 Reduced 5.0%	5,334 $354,000
Q4 2021 Jan 31, 2022	BUY	$54.02 - $63.83 $8,211 - $9,702	152 Added 2.78%	5,615 $327,000
Q3 2021 Nov 04, 2021	BUY	$55.56 - $60.79 $303,524 - $332,095	5,463 New	5,463 $328,000
Q2 2021 Aug 06, 2021	SELL	$48.42 - $60.18 $225,830 - $280,679	-4,664 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$48.42 - $60.18 $50,889 - $63,249	-1,051 Reduced 18.39%	4,664 $279,000
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $269,519 - $311,124	5,715 New	5,715 $284,000

Others Institutions Holding AZN

# of Institutions

1,248

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $238B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.

Account